Virtual Seminar on Phase I GMPs

  • 545.00 Dollar US$
  • Published date: January 21, 2019
    • Fremont, California, United States

Early clinical trials are conducted to establish initial safety of a drug.The studies are generally in small number of healthy subjects and use lower doses of the drug product. Therefore, only small amounts of investigational material are required. In order to not undertake substantial costs and to reduce regulatory burden during these early stages, the FDA has established guidelines to allow early stage investigational products to be manufactured under less stringent GMPs.

This workshop will review the current regulations, guidance documents for early stage manufacturing and GMPs in detail. Regulatory strategies and logistical considerations for early development stage product, including vendor selection and management, stability, labeling, and documentation requirements will also be reviewed and explored.

Why you should attend
Attend this conference so that you may understand differences between GMP requirements for early and later stage clinical development. Explore and discuss ways to develop and implement strategies for early GMPs for phase I clinical studies.

Who Will Benefit
Directors
Managers
Supervisors in Regulatory Affairs
Manufacturing
Quality Assurance
Clinical Operations

Speaker Profile
Peggy J. Berry , MBA, RAC, is the President & CEO at Synergy Consulting where she provides consulting services to companies in all aspects of drug development. She also provides group and one-on-one training in drug development, regulatory affairs and project management topics. Prior to founding Synergy Consulting in 2015, she was Vice President of Regulatory Affairs at Insmed (2/2015-5/2015) where she was responsible for the development and implementation of global regulatory strategies and the management and oversight of the regulatory affairs department. Prior to Insmed, she was Vice President of Regulatory Affairs and Quality at Amarin (3/2009-2/2014).

Result 0 votes
John Robinson
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Rabbit anti-SARS-CoV-2 spike glycoprotein monoclonal antibody, clone 118

    Rabbit anti-SARS-CoV-2 spike glycoprotein monoclonal antibody, clone 118

    Other Services Shirley (New York) September 30, 2020 1.00 Dollar US$

    The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell. Known receptors bind S1 are ACE2, angiotensin-converting enzyme 2; DPP4, dipeptidyl peptidase-4; APN, aminopeptidase N; CEACAM...

  • Recombinant SARS-CoV-2 Spike Protein 1 [His]

    Recombinant SARS-CoV-2 Spike Protein 1 [His]

    Other Services Shirley (New York) September 30, 2020 1.00 Dollar US$

    The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell: they are essential for both host specificity and viral infectivity. The term 'peplomer' is typically used to refer to a groupi...

  • DiagPoly™ Blue Coloured, Carboxyl Polystyrene Particles, 0.3-0.39 µm

    DiagPoly™ Blue Coloured, Carboxyl Polystyrene Particles, 0.3-0.39 µm

    Other Services Shirley (New York) September 30, 2020 1.00 Dollar US$

    DiagPoly™ Blue Coloured, Carboxyl Polystyrene Particles, 0.3-0.39 µm (# DDCB-S004) are carboxylated polystyrene particles with blue dyes encapsulated for colour visualization. The dyed particles are available to support covalent immobilization of bio...